AzTrials
AzTrials

Aspiration RiskGUSGANCT07292935

Gastric Ultrasound Versus Gastroscopic Aspiration

A study testing Gastric Ultrasound in people with Aspiration Risk and Full Stomach Status, run by Hôpital Fribourgeois at 1 site in Switzerland.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This is a prospective, single-center observational study conducted at the Fribourg Cantonal Hospital to evaluate the diagnostic performance of preoperative gastric ultrasound in determining gastric content and volume. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Gastric Ultrasound
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,390 participants
Where
1 siteSwitzerland
Study dates
Feb 2026to 31 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged ≥ 18 years
  • Indication for gastroscopy (scheduled or urgent), allowing complete aspiration of gastric contents
  • Feasibility of performing gastric ultrasound within one hour prior to the endoscopic procedure
  • Provision of written informed consent

Who cannot join

  • Pregnancy
  • History of major gastric or esophageal surgery
  • Known disorders of gastric emptying (e.g., gastroparesis, gastric outlet obstruction)
  • Cognitive impairment or language barriers preventing understanding of the study protocol
  • Active vomiting or technical impossibility to aspirate gastric contents

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Switzerland1 site
  • HFR

    Villars-sur-Glâne, Canton of Fribourg, 1752

    hadhami Abdouli, Docteur, +41 26 306 33 91 ext. 63391, hadhami.abdouli@h-fr.ch

    hadhamiabdouli@gmail.com

Other trials in Switzerland

About this study

Official title: Diagnostic Performance of Preoperative Gastric Ultrasound Compared to Gastroscopic Aspiration: A Prospective Clinical Study

This is a prospective, single-center observational study conducted at the Fribourg Cantonal Hospital to evaluate the diagnostic performance of preoperative gastric ultrasound in determining gastric content and volume. Upper gastrointestinal endoscopy with complete suction of gastric contents serves as the reference standard.

Adult patients (≥ 18 years) scheduled for elective or urgent gastroscopy are consecutively recruited. A gastric ultrasound is performed within one hour before the endoscopic procedure. The antral cross-sectional area is measured in standardized positions (supine and right lateral decubitus), and gastric volume is estimated using validated formulas. Gastric content is categorized into three grades (empty, low-risk liquid content, or high-risk/solid content).

Read more

During gastroscopy, complete aspiration of gastric contents is performed at the start of the procedure. The aspirated volume and qualitative characteristics (liquid vs. solid) are recorded, and the stomach is classified as empty, partially full, or full by the endoscopist.

The primary objective is to determine the accuracy of gastric ultrasound in identifying a full stomach. Secondary objectives include evaluating the qualitative agreement between ultrasound and gastroscopy, correlating estimated gastric volume with aspirated volume, and identifying an optimal ultrasound-based volume threshold predictive of a full stomach.

Approximately 1,390 patients will be enrolled over one year to obtain at least 139 "full stomach" cases, based on prevalence estimates and sample size calculations. Statistical analyses will include diagnostic performance metrics, Cohen's kappa, correlation tests, Bland-Altman plots, and ROC curve analysis.

Read the detailed description

Study Procedure and Conduct Each participant enrolled in the study will undergo a standardized two-step assessment protocol, consisting of a preoperative gastric ultrasound followed by a gastroscopy with complete aspiration of gastric contents. These procedures will be performed within a maximum interval of one hour, and conducted at Fribourg Cantonal Hospital within the Departments of Anesthesiology and Gastroenterology. All examinations will be performed by trained and credentialed operators, adhering to validated clinical protocols.

Following the acquisition of written informed consent, baseline demographic and clinical data will be collected. Gastric ultrasound will then be performed using a portable ultrasound device equipped with a low-frequency curvilinear transducer. The patient will be positioned sequentially in the supine and right lateral decubitus positions, with the upper body inclined at 45°, to obtain sagittal views of the gastric antrum. Antral diameters (antero-posterior and cranio-caudal) will be measured in each position, and the cross-sectional antral area (CSA) will be calculated accordingly. The estimated gastric volume (EGV) will be derived using the validated formula proposed by Perlas et al. Gastric contents will be classified into three qualitative grades (Grade 0 to 2), enabling stratification of aspiration risk.

Within one hour of the ultrasound, a diagnostic gastroscopy will be performed by an experienced gastroenterologist, following routine clinical practice. Immediately upon endoscope insertion and prior to any irrigation, complete aspiration of gastric contents will be performed to allow accurate measurement of the intragastric volume. The contents will be assessed macroscopically for appearance (e.g., clear, cloudy, bilious, alimentary) and consistency (liquid or solid). The aspirated volume will be quantified using a calibrated, graduated container. Based on visual assessment, the stomach will be classified as empty, partially full, or full.

All collected data will be documented using standardized case report forms and entered into a secure, anonymized database for subsequent statistical analysis.

Being tested
Gastric Ultrasound
Keywords
Gastric Ultrasound, Gastroscopy, Estimated Gastric Volume, Preoperative Evaluation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gastric UltrasoundDiagnostic test

    All enrolled participants undergo a preoperative gastric ultrasound within one hour prior to the scheduled gastroscopy. The gastric antrum is measured in standardized positions, and estimated gastric volume is calculated.

Study groups in NCT07292935
Study groupRoleWhat they receive
Gastric Ultrasound and GastroscopyOtherSingle Group - Diagnostic Assessment
Receives: Diagnostic Test: Gastric Ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the diagnostic accuracy of gastric ultrasound in identifying a full stomach, using gastroscopy with aspiration as the reference standard.

    Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy of preoperative gastric ultrasound in identifying a full stomach, compared to gastroscopy with complete aspiration of gastric contents. Gastric content is classified as empty, low-risk liquid content, or high-risk/solid content.

    Measured: Within 1 hour prior to gastroscopy

Secondary outcomes (3)
  1. Correlation coefficient between ultrasound-estimated gastric volume and aspirated gastric content volume during gastroscopy

    Gastric volume is estimated by preoperative ultrasound and compared with the volume of gastric content aspirated during gastroscopy. The Pearson or Spearman correlation coefficient is calculated depending on data distribution.

    Measured: Within 1 hour prior to gastroscopy

  2. Cohen's kappa coefficient for agreement between ultrasound and gastroscopy regarding gastric content nature

    Agreement between gastric ultrasound and gastroscopy for classification of gastric content nature (clear liquid, turbid liquid, solid) is assessed using Cohen's kappa coefficient.

    Measured: Within 1 hour prior to gastroscopy

  3. Optimal estimated gastric volume (EGV) threshold for predicting a full stomach

    Determination of the optimal threshold of estimated gastric volume (EGV) measured by preoperative ultrasound for predicting a full stomach, using receiver operating characteristic (ROC) curve analysis. Sensitivity, specificity, and area under the ROC curve (AUC) will be calculated.

    Measured: Within 1 hour prior to gastroscopy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2025
  2. Study startFeb 2026 (estimated)
  3. Primary completion31 Jan 2027 (estimated)
  4. Study completion31 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Model description
This is a prospective, single-group observational study in which all participants undergo both the index test (preoperative gastric ultrasound) and the reference standard (gastroscopy with complete aspiration). Gastric ultrasound is performed within one hour prior to gastroscopy. No randomization or parallel groups are involved. The study is designed to evaluate the diagnostic accuracy of ultrasound in detecting a full stomach and to compare estimated gastric volume with aspirated gastric volume.
Masking
None (open label)
Enrolment
1,390 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07292935
Sponsor's protocol ID
GUSGA-2025
Acronym
GUSGA
Status last verified
Dec 2025
First submitted
6 Dec 2025
Last updated
24 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The shared individual participant data (IPD) will include only the data used in the publication of the study results, specifically: * Gastric ultrasound measurements (antral cross-sectional area, estimated gastric volume, gastric content grade) * Gastroscopy findings (aspirated gastric volume, qualitative gastric content classification) * Basic participant characteristics (age, sex, weight)

Questions about this trial

What is this clinical trial studying?

A study testing Gastric Ultrasound in people with Aspiration Risk and Full Stomach Status, run by Hôpital Fribourgeois at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hadhami Abdouli, Docteur (+41 26 306 33 91 ext. 63391, hadhami.abdouli@h-fr.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the diagnostic accuracy of gastric ultrasound in identifying a full stomach, using gastroscopy with aspiration as the reference standard. (time frame: Within 1 hour prior to gastroscopy). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in